Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov;598(21):2670-2682.
doi: 10.1002/1873-3468.15020. Epub 2024 Sep 19.

The splicing factor hnRNPL demonstrates conserved myocardial regulation across species and is altered in heart failure

Affiliations

The splicing factor hnRNPL demonstrates conserved myocardial regulation across species and is altered in heart failure

Isabelle Draper et al. FEBS Lett. 2024 Nov.

Abstract

Heart failure (HF) is highly prevalent. Mechanisms underlying HF remain incompletely understood. Splicing factors (SF), which control pre-mRNA alternative splicing, regulate cardiac structure and function. This study investigated regulation of the splicing factor heterogeneous nuclear ribonucleoprotein-L (hnRNPL) in the failing heart. hnRNPL protein increased in left ventricular tissue from mice with transaortic constriction-induced HF and from HF patients. In left ventricular tissue, hnRNPL was detected predominantly in nuclei. Knockdown of the hnRNPL homolog Smooth in Drosophila induced cardiomyopathy. Computational analysis of predicted mouse and human hnRNPL binding sites suggested hnRNPL-mediated alternative splicing of tropomyosin, which was confirmed in C2C12 myoblasts. These findings identify hnRNPL as a sensor of cardiac dysfunction and suggest that disturbances of hnRNPL affect alternative splicing in HF.

Keywords: cardiomyopathy; heart failure; hnRNPL; mRNA splicing; splicing factors.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST & ETHICS STATEMENT

The authors declare no conflicts of interest.

References

    1. Martin SS, Aday AW, Almarzooq ZI, et al. 2024. Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association. Circulation. Jan 24 2024;doi:10.1161/cir.0000000000001209 - DOI - PubMed
    1. Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. May 3 2022;79(17):1757–1780. doi:10.1016/j.jacc.2021.12.011 - DOI - PubMed
    1. Alexander MS, Hightower RM, Reid AL, et al. hnRNP L is essential for myogenic differentiation and modulates myotonic dystrophy pathologies. Muscle Nerve. Jun 2021;63(6):928–940. doi:10.1002/mus.27216 - DOI - PMC - PubMed
    1. Gupta MP. Factors controlling cardiac myosin-isoform shift during hypertrophy and heart failure. J Mol Cell Cardiol. Oct 2007;43(4):388–403. doi:10.1016/j.yjmcc.2007.07.045 - DOI - PMC - PubMed
    1. Hu J, Gao C, Wei C, et al. RBFox2-miR-34a-Jph2 axis contributes to cardiac decompensation during heart failure. Proc Natl Acad Sci U S A. Mar 26 2019;116(13):6172–6180. doi:10.1073/pnas.1822176116 - DOI - PMC - PubMed

Substances

LinkOut - more resources